EUVIMEDEUVIMED entdecken
Vergleichsstudie

Spatially fractionated radiotherapy using straight and bending virtual rods as an alternative for cervical cancer brachytherapy—results from preclinical in-silico dose comparison and quality assurance

Prakash Shinde, Anjana Ak, Priyanka Agarwal, J Kamalnath, Kishor Joshi, Kunal Prajapati, Jeevanshu Jain, Jaahid Mulani, Ankita Gupta, Prachi Mittal iD, Prachi Sawant, Jai Parkash Agarwal und 2 weitere

British Journal of Radiology · 01.08.2026 · 99 (1184) · 1551-1557

DOI: 10.1093/bjr/tqag075 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift British Journal of Radiology, online erschienen am 21.05.2026. Verfasst von Prakash Shinde und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Advanced Centre for Treatment Research and Education in Cancer, Tata Memorial Centre, Homi Bhabha National Institut…. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Brachytherapy, Dose Fractionation, Radiation, Radiotherapy Planning, Computer-Assisted. Die Arbeit nennt 23 Literaturangaben. Gefördert von: Varian.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To compare virtual straight and bending rods Spatially Fractionated Radiation Therapy (SFRT) for cervical cancer brachytherapy delivery.

Methods

CT scan datasets from 10 patients with locally advanced cervical cancer who received brachytherapy were included. For each patient, 2 distinct plans were generated: one using straight virtual rods and the other using bending virtual rods. The total prescribed dose was 30 Gy in 5 fractions. All plans were created with 10XFFF beam. Dosimetric parameters, including D90, V100%, V150%, and V200% for high-risk clinical target volume (HRCTV), were evaluated. Additionally, dose constraints for OARs (bladder, rectum, sigmoid, and bowel D2cc) were compared. Plan delivery quality assurance was performed using the Mobius verification phantom, and gamma passing rate was analyzed.

Results

Comparable CTV coverage was observed between the 2 configurations. D90 values showing no statistically significant difference (P > .05). In both plans, the D2cc of bladder, rectum, sigmoid, and bowel were observed to be ≤23.75 Gy, ≤17.00 Gy, ≤19.50 Gy, and ≤17.00 Gy, respectively. The average hotspot in HRCTV was evaluated at 18.4% (±10.4) and 20.8% (±7.8) for V200%, respectively. The gamma passing rate was found to be greater than 90% for the 2%/2 mm criteria.

Conclusions

This in-silico study concludes that both virtual rod configurations provide comparable target coverage while effectively minimizing OAR exposure. Further clinical validation is recommended to confirm these findings. Advances in knowledge This study demonstrates the feasibility of SFRT and the potential for future testing in patients who are unable to undergo brachytherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Uterine Cervical NeoplasmsBrachytherapyDose Fractionation, RadiationRadiotherapy Planning, Computer-AssistedHumansFemaleQuality Assurance, Health CareRadiotherapy DosageOrgans at RiskTomography, X-Ray ComputedComputer SimulationPhantoms, Imaging

Stichwörter der Autor:innen

RapidArcSFRT plan ValidationVMATcervix cancerin-silico modelspatially fractionated radiation therapyvirtual brachytherapyvirtual rods

Autor:innen und Institutionen

  • Department of Radiation Oncology, Advanced Centre for Treatment Research and Education in Cancer, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai 410210, India.
  • Medical Affairs, Varian Medical Systems, Siemens Healthineers Company, New Delhi 110017, India.
  • Department of Radiation Oncology, Tata Memorial Hospital, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai 400012, India.
  • Radiotherapy and Radiosurgery Department, Humanitas Research Hospital and Cancer Center, 20089 Milan-Rozzano, Italy.
  • Medical Affairs, Varian Medical Systems, a Siemens Healthineers Company, Palo Alto, CA 94304, United States.

ORCID-Profile: Prachi Mittal, Supriya Chopra

Förderung

  • Varian

Zitieren

APA

Shinde, P., Ak, A., Agarwal, P., Kamalnath, J., Joshi, K., Prajapati, K., Jain, J., Mulani, J., Gupta, A., Mittal, P., Sawant, P., Agarwal, J. P., Cozzi, L., & Chopra, S. (2026). Spatially fractionated radiotherapy using straight and bending virtual rods as an alternative for cervical cancer brachytherapy—results from preclinical in-silico dose comparison and quality assurance. British Journal of Radiology, 99(1184), 1551-1557. https://doi.org/10.1093/bjr/tqag075

Vancouver

Shinde P, Ak A, Agarwal P, Kamalnath J, Joshi K, Prajapati K, et al. Spatially fractionated radiotherapy using straight and bending virtual rods as an alternative for cervical cancer brachytherapy—results from preclinical in-silico dose comparison and quality assurance. British Journal of Radiology. 2026;99(1184):1551-1557. doi:10.1093/bjr/tqag075

BibTeX
@article{Shinde2026,
  author = {Shinde, Prakash and Ak, Anjana and Agarwal, Priyanka and Kamalnath, J and Joshi, Kishor and Prajapati, Kunal and Jain, Jeevanshu and Mulani, Jaahid and Gupta, Ankita and Mittal, Prachi and Sawant, Prachi and Agarwal, Jai Parkash and Cozzi, Luca and Chopra, Supriya},
  title = {Spatially fractionated radiotherapy using straight and bending virtual rods as an alternative for cervical cancer brachytherapy—results from preclinical in-silico dose comparison and quality assurance},
  journal = {British Journal of Radiology},
  year = {2026},
  volume = {99},
  number = {1184},
  pages = {1551--1557},
  doi = {10.1093/bjr/tqag075}
}
Kostenlos starten →